Incidence of acute radiodermatitis in women with breast cancer undergoing hypofractionated radiotherapy

• Autor(a) principal: Martelletti,Laura Beatriz Sousa de Jesus
• Data de Publicação: 2022
• Outros Autores: Aguiar,Beatriz Regina Lima de, Vieira,Larissa Aparecida Corrêa, Menêses,Amanda Gomes de, Bontempo,Priscila de Sousa Maggi, Ferreira,Elaine Barros, Reis,Paula Elaine Diniz dos
• Tipo de documento: Artigo
• Idioma: eng
• Título da fonte: Revista Brasileira de Enfermagem (Online)
• Texto Completo: http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0034-71672022000100178
• topic: Radiodermatitis; Radiotherapy; Radiation dose Hypofractionation; Breast Neoplasms; Oncology Nursing

ABSTRACT Objective: To estimate the incidence and degree of acute radiodermatitis at the end and after the end of treatment in women with breast cancer undergoing hypofractionated radiotherapy. Methods: Observational, prospective, and longitudinal study, conducted between March 2019 and January 2020, in a radiotherapy outpatient clinic. Results: Thirty-two women participated in the study, among whom, in the last session of hypofractionated radiotherapy, 15 (46.9%) had radiodermatitis, erythema in 13 (40.6%), and wet peeling in 2 (6.3%). In the post-treatment evaluation, 27 (84.4%) had radiodermatitis, erythema in 17 (53.1%), dry peeling in 8 (25%), and wet peeling in 2 (6.3%). Conclusion: The general incidence of radiodermatitis after hypofractionated radiotherapy in women with breast cancer was 37.5%, erythema, 12.5%, and dry peeling, 25%. The development of care protocols for the management of radiodermatitis after treatment is of paramount importance.